Central line-associated bloodstream infections: prevention and management

Area of Science:

• Infectious Diseases
• Healthcare Epidemiology
• Medical Microbiology

Background:

• Central venous line-associated bloodstream infections (CLA-BSI) represent a significant cause of morbidity and mortality, with approximately 80,000 cases occurring annually in the United States.
• Common causative pathogens include coagulase-negative staphylococci, Staphylococcus aureus, Candida spp., and aerobic gram-negative bacilli.
• Microbial entry into the bloodstream typically occurs at the catheter-skin interface or through the catheter hub.

Purpose of the Study:

• To review the epidemiology and common causative agents of CLA-BSI.
• To highlight the critical role of aseptic technique in CLA-BSI prevention.
• To discuss various interventions aimed at reducing CLA-BSI rates.

Main Methods:

• Review of existing literature on CLA-BSI epidemiology and prevention.
• Analysis of common microbial pathways for bloodstream invasion.
• Evaluation of established and emerging preventive strategies.

Main Results:

• Strict aseptic technique during central venous line insertion is paramount for preventing CLA-BSI.
• Antimicrobial-impregnated catheters, daily chlorhexidine bathing, and chlorhexidine-impregnated sponges are effective in reducing CLA-BSI.
• These interventions target the primary routes of microbial contamination.

Conclusions:

• CLA-BSI remains a substantial clinical challenge, necessitating robust preventive measures.
• A multi-faceted approach combining aseptic technique with targeted antimicrobial strategies is crucial for effective CLA-BSI control.
• Continued vigilance and implementation of evidence-based practices are essential to minimize the burden of these infections.